Trade Pacific Biosciences of California Inc - PACB
Pacific BiosciencesLatest shares articles

Rocket Lab stock forecast: Iridium acquisition equity funding
Rocket Lab is a US space company listed on Nasdaq. On 15 September, it completed a $1.944bn equity offering to fund its pending acquisition of Iridium Communications. Explore third-party RKLB price targets. Past performance is not a reliable indicator of future results.
6 hours ago

Bitfarms stock forecast: $819m liquidity, no tenant yet
Keel Infrastructure became Bitfarms’ parent company in April 2026, with the group shifting towards data-centre development. Explore third-party KEEL price targets and technical analysis. Past performance is not a reliable indicator of future results.
7 hours ago

Air Liquide stock forecast: Elliott stake, hydrogen initiative
Air Liquide is a French industrial gases group. Reuters reported that Elliott Investment Management built a stake, while Air Liquide joined a European hydrogen mobility initiative. Explore third-party AI price targets. Past performance is not a reliable indicator of future results.
7 hours ago

Allianz stock forecast: record H1 profit, Q3 earnings ahead
Allianz is a German insurer whose shares are trading near record levels following record first-half operating profit and reports of a possible €5.8 billion acquisition of AA. Explore third-party ALV targets and technicals. Past performance is not a reliable indicator of future results.
13:26, 30 September 2026